Granite Point Capital Management, L.P. Nevro Corp Transaction History

Granite Point Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$69.46 - $88.57 $1.89 Million - $2.41 Million	-27,200 Closed	0 $0
Q4 2017 Feb 08, 2018	SELL	$65.94 - $93.31 $59,346 - $83,979	-900 Reduced 3.2%	27,200 $1.88 Million
Q3 2017 Nov 14, 2017	SELL	$80.87 - $91.08 $315,393 - $355,212	-3,900 Reduced 12.19%	28,100 $2.55 Million
Q2 2017 Aug 10, 2017	BUY	N/A	32,000	32,000 $2.38 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.